Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Schneck

Showing results (91-100 of 165) with videos related to

Pageof 17
Sort By:
Annals of the New York Academy of Sciences|September 7, 1995
Csk associates with the TCR zeta and epsilon chains through its SH2 domainT Rafnar, J P Schneck, M E Brummet, et al.
Oncotarget|September 8, 2018
Correction: Antigen-specific T cell Redirectors: a nanoparticle based approach for redirecting T cellsChristian Schütz, Juan Carlos Varela, Karlo Perica, et al.
Oncotarget|September 8, 2016
Antigen-specific T cell Redirectors: a nanoparticle based approach for redirecting T cellsChristian Schütz, Juan Carlos Varela, Karlo Perica, et al.
ACS Nano|February 26, 2014
Magnetic field-induced T cell receptor clustering by nanoparticles enhances T cell activation and stimulates antitumor activityKarlo Perica, Ang Tu, Anne Richter, et al.
ACS Nano|June 8, 2017
Dual Targeting Nanoparticle Stimulates the Immune System To Inhibit Tumor GrowthAlyssa K Kosmides, John-William Sidhom, Andrew Fraser, et al.
Immunology Today|April 22, 1999
MHC-based diagnostics and therapeutics - clinical applications for disease-linked genesM C Howard, E G Spack, K Choudhury, et al.
Immunity, Inflammation and Disease|December 16, 2014
MHC-Ig induces memory T cell formation in vivo and inhibits tumour growthChristian Schütz, Alessia Zoso, Shiwen Peng, et al.
Nature Medicine|April 22, 2003
Ex vivo induction and expansion of antigen-specific cytotoxic T cells by HLA-Ig-coated artificial antigen-presenting cellsMathias Oelke, Marcela V Maus, Dominic Didiano, et al.
The Journal of Infectious Diseases|December 20, 2000
Increased activated human T cell lymphotropic virus type I (HTLV-I) Tax11-19-specific memory and effector CD8+ cells in patients with HTLV-I-associated myelopathy/tropical spastic paraparesis: correlation with HTLV-I provirus loadM Nagai, R Kubota, T F Greten, et al.
Cancer Immunology, Immunotherapy : CII|June 20, 2008
In vivo functional efficacy of tumor-specific T cells expanded using HLA-Ig based artificial antigen presenting cells (aAPC)Malarvizhi Durai, Christine Krueger, Zhaohui Ye, et al.
Pageof 17

Showing results (91-100 of 165) with videos related to

Sort By:
Pageof 17
Annals of the New York Academy of Sciences|September 7, 1995
Csk associates with the TCR zeta and epsilon chains through its SH2 domainT Rafnar, J P Schneck, M E Brummet, et al.
Oncotarget|September 8, 2018
Correction: Antigen-specific T cell Redirectors: a nanoparticle based approach for redirecting T cellsChristian Schütz, Juan Carlos Varela, Karlo Perica, et al.
Oncotarget|September 8, 2016
Antigen-specific T cell Redirectors: a nanoparticle based approach for redirecting T cellsChristian Schütz, Juan Carlos Varela, Karlo Perica, et al.
ACS Nano|February 26, 2014
Magnetic field-induced T cell receptor clustering by nanoparticles enhances T cell activation and stimulates antitumor activityKarlo Perica, Ang Tu, Anne Richter, et al.
ACS Nano|June 8, 2017
Dual Targeting Nanoparticle Stimulates the Immune System To Inhibit Tumor GrowthAlyssa K Kosmides, John-William Sidhom, Andrew Fraser, et al.
Immunology Today|April 22, 1999
MHC-based diagnostics and therapeutics - clinical applications for disease-linked genesM C Howard, E G Spack, K Choudhury, et al.
Immunity, Inflammation and Disease|December 16, 2014
MHC-Ig induces memory T cell formation in vivo and inhibits tumour growthChristian Schütz, Alessia Zoso, Shiwen Peng, et al.
Nature Medicine|April 22, 2003
Ex vivo induction and expansion of antigen-specific cytotoxic T cells by HLA-Ig-coated artificial antigen-presenting cellsMathias Oelke, Marcela V Maus, Dominic Didiano, et al.
The Journal of Infectious Diseases|December 20, 2000
Increased activated human T cell lymphotropic virus type I (HTLV-I) Tax11-19-specific memory and effector CD8+ cells in patients with HTLV-I-associated myelopathy/tropical spastic paraparesis: correlation with HTLV-I provirus loadM Nagai, R Kubota, T F Greten, et al.
Cancer Immunology, Immunotherapy : CII|June 20, 2008
In vivo functional efficacy of tumor-specific T cells expanded using HLA-Ig based artificial antigen presenting cells (aAPC)Malarvizhi Durai, Christine Krueger, Zhaohui Ye, et al.
Pageof 17